Metformin is a medication commonly prescribed for type two diabetics. Metformin is also sold as Glucophage, Fortamet, and Glumetza. A recent study in the scientific research journal of the Brazilian medical association found a high prevalence of vitamin B12 deficiency in Metformin treated diabetic patients.
Vitamin B12 is a water soluble vitamin that is naturally present in foods such as fish, shellfish, poultry, milk, eggs and meat. Vitamin B12 is necessary proper function of your nervous system, the manufacture of red blood cells as well as to make DNA. Vitamin B12 is also associated with regulating Homocysteine levels which is associated with heart disease.
Symptoms associated with vitamin B12 deficiency include:
- feeling tired and weak
- tingling in the hands and feet
- trouble with balance and walking
- mood changes including depression
- weight loss.
- soreness of the tongue
- bleeding gums
- frequent bruising
- paleness of the skin.
Vitamin B12 levels are typically evaluated by serum or plasma analysis. This type of testing can be performed at any of your standard laboratories such as Quest Diagnostics and as such are readily available to patients in the United States .
Ten to thirty percent of those over 50 years of age suffer from a condition called atrophic gastritis. In atrophic gastritis, there are reduced levels of hydrochloric acid produced by the stomach. The consequence of this low hydrochloric acid production is diminished absorption of vitamin B12. Thus, if you are elderly and a diabetic taking metformin, the chances of your having a vitamin B12 deficiency increase.
Vegetarians, who by definition do not eat animal proteins, and are the most prevalent source of vitamin B12, and those with digestive disorders such as crohn's disease, also need to beware of possible B12 deficiency. Once again, this is especially true if coupled with being a diabetic was taking metformin.
If you're a diabetic and taking Metformin and feel that several of the signs and symptoms listed above pertain to you, contact your physician for a vitamin B12 analysis. Many physicians are not aware of the nutritional consequences of the medication they prescribe and therefore a visit to a functional medicine practitioner may be in order.
Mother sues U.S. hospital for discriminating against dead transgender son
The mother of a transgender boy filed a lawsuit against a U.S. hospital on Monday claiming its medical staff repeatedly addressed her son - who later committed suicide - as a girl. In the landmark case, Katharine Prescott argues the Rady Children's Hospital-San Diego (RCHSD) in California discriminated against her transgender son based on his sex. The 14-year-old transgender boy, Kyler Prescott, committed suicide about five weeks after staying at the hospital in 2015 where he was treated for having suicidal thoughts and self-inflicted wounds.
Cancer patients may be overly optimistic about early drug trial participation
By Andrew M. Seaman (Reuters Health) - People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to test the drug's safety. Just 4 percent to 20 percent of participants may see their cancer respond to the drug, the authors write in the journal Cancer.
Kite immunotherapy drug helps blood cancer patients in study
(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive non-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial. Shares of Kite, which had been halted before the release of the news, rose 11 percent when trading resumed. Some 76 percent of patients taking the drug, called KTE-C19, showed significant tumor shrinkage, including 47 percent who had no remaining signs of cancer at least three months after receiving the treatment, Kite said.
More U.S. babies born addicted to opiates like heroin
By Lisa Rapaport (Reuters Health) - The proportion of U.S. babies born suffering from withdrawal syndrome after exposure to heroin or prescription opiates in utero has more than doubled in less than a decade, a study suggests. Researchers focused on what’s known as neonatal abstinence syndrome, a condition akin to withdrawal that develops when babies essentially become addicted to drugs their mothers use during pregnancy. Nationally, the rate of neonatal abstinence syndrome involving mothers’ use of opiates - which includes heroin as well as prescription narcotics like codeine and Vicodin - surged from 2.8 cases for every 1,000 births in 2009 to 7.3 cases for every 1,000 births in 2013, the study found.
Walking is medicine? It helped high-risk seniors stay mobile
WASHINGTON (AP) — It's not too late to get moving: Simple physical activity — mostly walking — helped high-risk seniors stay mobile after disability-inducing ailments even if, at 70 and beyond, they'd long been couch potatoes.
Poor exercise habits may follow teens into adulthood
By Lisa Rapaport (Reuters Health) - Most American teenagers don’t get enough exercise, and they often stick with their sedentary ways as they enter adulthood, a U.S. study suggests. More than 9 in 10 adolescents fail to get the minimum 60 minutes of moderate to vigorous daily physical activity recommended by the U.S. Centers for Disease Control and Prevention (CDC), researchers report in the journal Pediatrics. “Physical inactivity is one of the major predictors of childhood and adolescent obesity, the consequences of which increases incidence of obesity as well as metabolic syndrome in adulthood,” said lead study author Kaigang Li, a researcher at Colorado State University in Fort Collins.
Mylan faces scrutiny over EpiPen profit data shown to Congress
Mylan has been widely criticized for sharply raising the price of EpiPens, which are carried by people with life-threatening allergies. Mylan, which acquired the product in 2007, has raised the list price for a pair of EpiPens to $600 from about $100 in 2008. Lawmakers are trying to determine whether Mylan made more money on EpiPen than warranted from state Medicaid programs by having it classified as a generic product, resulting in much smaller rebates to the government health plans.
Nestle executive Cantarell quits after 40 years, sparking reshuffle
Luis Cantarell, who heads Nestle's Europe, Middle East and North Africa zone and has been an advocate of blurring the lines between food and pharmaceuticals, is stepping down after 40 years, the Swiss company said on Monday. Cantarell will be replaced in January by Marco Settembri, head of Nestle's water division, which will now be run by Maurizio Paternello, who moves from Nestle Russia and Eurasia, the company said in a statement.
Drugmaker Pfizer decides not to break up business
TRENTON, N.J. (AP) — Drug giant Pfizer says it won't split into two publicly traded companies, despite pressure from investors frustrated by its lagging stock price, ending years of Wall Street speculation over its strategy and future.
Clovis short sellers undaunted as stock price surges
By Lewis Krauskopf NEW YORK (Reuters) - Clovis Oncology Inc's share price has doubled in the past month, fueled by positive developments for the company's experimental cancer drug and takeover speculation. The biotech company said late last month its experimental ovarian cancer treatment would be reviewed on a priority basis, with U.S. regulators expected to rule on the drug, rucaparib, by Feb 23. Shares of Clovis, which has climbed to a market value of about $1.4 billion, rose steadily in the past month, from $18.10 as of Aug 22 to $36.50 on Monday, also amid speculation about Clovis as a potential acquisition by a larger drugmaker.